Default company panoramic image


TissueNetix is developing the next generation cardiac liability assay for drug discovery and development.

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded November 2011
  • Employees 2
  • Website

Company Summary

TissueNetix is a startup life sciences company whose goal is to develop assay kits for chemical toxicity screening using human cells. The first product will be an assay to better predict cardiac liability side effects for drug discovery. The current standard cellular assay is poorly predictive of the potential of a drug to have cardiac liabilities. A more predictive assay is needed. The target market is companies involved in drug discovery.


  • Default avatar
    Robert Ellis

    Bob has 38 years of experience in analytical and biotechnology instrumentation.
    Bob was at Biotrove for six years where he held the Chairman, CEO and President positions. He was responsible for the product and business strategy that led to the successful acquisition of Biotrove‘s OpenArray® business by Life Technologies and the spinout of the Rapidfire® business into a separate company Biocius™ which was acquired by Agilent in 2011.

  • Default avatar
    David Giegel
    President & Founder

    Dr. Giegel has twenty years of experience in drug discovery management. Prior to TissueNetix, Dr. Giegel was the Senior Director of Molecular Sciences at Celgene, where he was responsible for the in vitro drug discovery efforts of the company's San Diego site. Dr. Giegel has been an Entrepreneur-in-Residence for CONNECT Springboard. In this role, Giegel helped first-time entrepreneurs develop business plans and prepare for potential investors.

  • Default avatar
    Sandra Hara
    CFO (Part time)

    Sandra brings the highest level of experience and personal service to the organization. That experience includes more than fifteen years in public accounting and tax, and another fifteen years in the private sector working with a wide range of companies from start-ups to companies with revenues of $500 Million. She has held positions of Controller, CFO and COO, giving her the wide range of knowledge to understand every business’ needs.


  • Default avatar
    Jake Handy, Fenwick & West
    Default avatar
    Sandra Hara, Hara CPA Professional Services